1. Home
  2. STIM vs MSD Comparison

STIM vs MSD Comparison

Compare STIM & MSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$1.23

Market Cap

140.6M

Sector

Health Care

ML Signal

HOLD

Logo Morgan Stanley Emerging Markets Debt Fund Inc.

MSD

Morgan Stanley Emerging Markets Debt Fund Inc.

HOLD

Current Price

$7.34

Market Cap

151.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
STIM
MSD
Founded
2003
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
140.6M
151.1M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
STIM
MSD
Price
$1.23
$7.34
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
1.6M
109.7K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
N/A
11.26%
EPS Growth
57.25
N/A
EPS
N/A
N/A
Revenue
$52,776,000.00
N/A
Revenue This Year
$11.10
N/A
Revenue Next Year
$11.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$6.91
52 Week High
$4.84
$7.94

Technical Indicators

Market Signals
Indicator
STIM
MSD
Relative Strength Index (RSI) 42.89 53.63
Support Level $1.21 $7.25
Resistance Level $1.75 $7.48
Average True Range (ATR) 0.12 0.08
MACD -0.01 0.01
Stochastic Oscillator 7.27 80.95

Price Performance

Historical Comparison
STIM
MSD

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

About MSD Morgan Stanley Emerging Markets Debt Fund Inc.

Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.

Share on Social Networks: